A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

NCT01388153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Acarbose (Glucobay ODT, BAYG5421)
DRUG: Acarbose (Glucobay ODT, BAYG5421)
DRUG: Acarbose (Glucobay, BAYG5421)

Sponsor

Bayer